175 related articles for article (PubMed ID: 31657061)
21. Design, synthesis, and biological evaluation of crenatoside analogues as novel influenza neuraminidase inhibitors.
Chen BL; Wang YJ; Guo H; Zeng GY
Eur J Med Chem; 2016 Feb; 109():199-205. PubMed ID: 26774928
[TBL] [Abstract][Full Text] [Related]
22. Discovery of novel 1,2,3-triazole oseltamivir derivatives as potent influenza neuraminidase inhibitors targeting the 430-cavity.
Ju H; Xiu S; Ding X; Shang M; Jia R; Huang B; Zhan P; Liu X
Eur J Med Chem; 2020 Feb; 187():111940. PubMed ID: 31835169
[TBL] [Abstract][Full Text] [Related]
23. Studies on synthesis and structure-activity relationship (SAR) of derivatives of a new natural product from marine fungi as inhibitors of influenza virus neuraminidase.
Li J; Zhang D; Zhu X; He Z; Liu S; Li M; Pang J; Lin Y
Mar Drugs; 2011; 9(10):1887-1901. PubMed ID: 22073001
[TBL] [Abstract][Full Text] [Related]
24. Discovery of novel acylhydrazone neuraminidase inhibitors.
Zhao ZX; Cheng LP; Li M; Pang W; Wu FH
Eur J Med Chem; 2019 Jul; 173():305-313. PubMed ID: 31022584
[TBL] [Abstract][Full Text] [Related]
25. Discovery of N-substituted oseltamivir derivatives as potent and selective inhibitors of H5N1 influenza neuraminidase.
Xie Y; Xu D; Huang B; Ma X; Qi W; Shi F; Liu X; Zhang Y; Xu W
J Med Chem; 2014 Oct; 57(20):8445-58. PubMed ID: 25255388
[TBL] [Abstract][Full Text] [Related]
26. Molecular modeling and lead design of substituted zanamivir derivatives as potent anti-influenza drugs.
Dholakia D; Goyal S; Jamal S; Singh A; Das A; Grover A
BMC Bioinformatics; 2016 Dec; 17(Suppl 19):512. PubMed ID: 28155702
[TBL] [Abstract][Full Text] [Related]
27. Discovery of C-1 modified oseltamivir derivatives as potent influenza neuraminidase inhibitors.
Ju H; Zhang J; Sun Z; Huang Z; Qi W; Huang B; Zhan P; Liu X
Eur J Med Chem; 2018 Feb; 146():220-231. PubMed ID: 29407952
[TBL] [Abstract][Full Text] [Related]
28. Discovery of Novel Pyrazole Derivatives as Potent Neuraminidase Inhibitors against Influenza H1N1 Virus.
Meng FJ; Sun T; Dong WZ; Li MH; Tuo ZZ
Arch Pharm (Weinheim); 2016 Mar; 349(3):168-74. PubMed ID: 26797880
[TBL] [Abstract][Full Text] [Related]
29. Pyrrolidinobenzoic acid inhibitors of influenza virus neuraminidase: the hydrophobic side chain influences type A subtype selectivity.
Li Y; Silamkoti A; Kolavi G; Mou L; Gulati S; Air GM; Brouillette WJ
Bioorg Med Chem; 2012 Jul; 20(14):4582-9. PubMed ID: 22677529
[TBL] [Abstract][Full Text] [Related]
30. Peramivir Phosphonate Derivatives as Influenza Neuraminidase Inhibitors.
Wang PC; Fang JM; Tsai KC; Wang SY; Huang WI; Tseng YC; Cheng YS; Cheng TJ; Wong CH
J Med Chem; 2016 Jun; 59(11):5297-310. PubMed ID: 27167096
[TBL] [Abstract][Full Text] [Related]
31. Design, in silico studies, synthesis and in vitro evaluation of oseltamivir derivatives as inhibitors of neuraminidase from influenza A virus H1N1.
Neri-Bazán RM; García-Machorro J; Méndez-Luna D; Tolentino-López LE; Martínez-Ramos F; Padilla-Martínez II; Aguilar-Faisal L; Soriano-Ursúa MA; Trujillo-Ferrara JG; Fragoso-Vázquez MJ; Barrón BL; Correa-Basurto J
Eur J Med Chem; 2017 Mar; 128():154-167. PubMed ID: 28182988
[TBL] [Abstract][Full Text] [Related]
32. Discovery of berberine based derivatives as anti-influenza agent through blocking of neuraminidase.
Enkhtaivan G; Muthuraman P; Kim DH; Mistry B
Bioorg Med Chem; 2017 Oct; 25(20):5185-5193. PubMed ID: 28958846
[TBL] [Abstract][Full Text] [Related]
33. In search of effective H1N1 neuraminidase inhibitor by molecular docking, antiviral evaluation and membrane interaction studies using NMR.
Malbari K; Gonsalves H; Chintakrindi A; Gohil D; Joshi M; Kothari S; Srivastava S; Chowdhary A; Kanyalkar M
Acta Virol; 2018; 62(2):179-190. PubMed ID: 29895159
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, antiviral activity, and molecular docking study of trans-ferulic acid derivatives containing acylhydrazone moiety.
Wang Z; Xie D; Gan X; Zeng S; Zhang A; Yin L; Song B; Jin L; Hu D
Bioorg Med Chem Lett; 2017 Sep; 27(17):4096-4100. PubMed ID: 28751145
[TBL] [Abstract][Full Text] [Related]
35. Discovery of highly potent and selective influenza virus neuraminidase inhibitors targeting 150-cavity.
Jia R; Zhang J; Bertagnin C; Cherukupalli S; Ai W; Ding X; Li Z; Zhang J; Ju H; Ma X; Loregian A; Huang B; Zhan P; Liu X
Eur J Med Chem; 2021 Feb; 212():113097. PubMed ID: 33385836
[TBL] [Abstract][Full Text] [Related]
36. Antiviral Activity of Benzoic Acid Derivative NC-5 Against Influenza A Virus and Its Neuraminidase Inhibition.
Guo M; Ni J; Yu J; Jin J; Ma L; Zhang H; Wang D; Zhang X; Dou J; Zhou C
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31842256
[TBL] [Abstract][Full Text] [Related]
37. Design and synthesis of 1,2,3-triazole-containing N-acyl zanamivir analogs as potent neuraminidase inhibitors.
Das A; Adak AK; Ponnapalli K; Lin CH; Hsu KC; Yang JM; Hsu TA; Lin CC
Eur J Med Chem; 2016 Nov; 123():397-406. PubMed ID: 27487569
[TBL] [Abstract][Full Text] [Related]
38. Discovery of novel thiophene derivatives as potent neuraminidase inhibitors.
Zhong ZJ; Hu XT; Cheng LP; Zhang XY; Zhang Q; Zhang J
Eur J Med Chem; 2021 Dec; 225():113762. PubMed ID: 34411893
[TBL] [Abstract][Full Text] [Related]
39. Five Novel Non-Sialic Acid-Like Scaffolds Inhibit In Vitro H1N1 and H5N2 Neuraminidase Activity of Influenza a Virus.
Márquez-Domínguez L; Reyes-Leyva J; Herrera-Camacho I; Santos-López G; Scior T
Molecules; 2020 Sep; 25(18):. PubMed ID: 32947893
[TBL] [Abstract][Full Text] [Related]
40. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC
Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
